Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine-Reference-Cited by-同舟云学术

Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine

Published:2017-11 Issue: Volume:16 Page:S14-S23
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Dorsey Jill,Gonska Tanja

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference76 articles.

1. Cystic Fibrosis Canada. 2015-2016 Annual Report. The Canadian cystic fibrosis patient data registry [[online], http://www.cysticfibrosis.ca/uploads/annual%20reports/2015annual-report-english-for-web.pdf]

2. The cystic fibrosis intestine;De Lisle;Cold Spring Harb Perspect Med,2013

3. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion;Garcia;J Clin Invest,2009

4. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine;Norkina;Infect Immun,2004

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased activity of epithelial Cdc42 Rho GTPase and tight junction permeability in the Cftr knockout intestine;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

2. A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI);Journal of Cystic Fibrosis;2024-09

3. Improving growth in infants with CF;Pediatric Pulmonology;2024-08-06

4. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis;Pediatric Pulmonology;2024-08-06

5. Constipation and DIOS: Diagnosis, differential diagnosis, and management;Pediatric Pulmonology;2024-08-06